PHILADELPHIA, Feb. 27, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against Varonis Systems, Inc. (NASDAQ: VRNS) (“Varonis” or the “Company”) on behalf of investors who purchased or otherwise acquired Varonis securities during the period of February 4, 2025 through October 28, 2025 (the “Class Period”). Investor Deadline: Investors who purchased Varonis securities during the Class Period may, no later than March 9, 2026, seek ...

Philadelphia, Pennsylvania--(Newsfile Corp. - February 26, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Richtech Robotics Inc. (NASDAQ: RR) ("Richtech" or the "Company") on behalf of investors who purchased Richtech securities during the period from January 27, 2026 through January 29, 2026 (the "Class Period").Investor Deadline: Investors who purchased Richtech securities during the Class Period may, no later than April 3, 2026, seek ...

PHILADELPHIA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against Masonite International Corporation (NYSE: DOOR) (“Masonite” or the “Company”) on behalf of investors who sold Masonite common stock during the period from June 5, 2023 through February 8, 2024 (the “Class Period”). Investor Deadline: Investors who sold Masonite securities during the Class Period may, no later than April 7, 2026, seek to be appointed as ...

Core Viewpoint - A class action lawsuit has been filed against Navan, Inc. for allegedly misleading investors regarding its IPO documents, particularly concerning undisclosed increases in sales and marketing expenses [1][3]. Group 1: Lawsuit Details - The lawsuit is initiated by Berger Montague PC on behalf of investors who acquired Navan shares from October 28, 2025, to February 23, 2026, including during the IPO [1][2]. - Investors have until April 24, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Financial Impact - Navan's shares have seen a significant decline, trading as low as $9.01 per share, which represents a drop of over 60% from the IPO price of $25 per share [3]. - The decline in share price has resulted in substantial losses for investors as the true state of the company's business was revealed [3]. Group 3: Company Overview - Navan, headquartered in Palo Alto, California, specializes in booking and expense reporting software for business travelers [2].

Core Viewpoint - A class action lawsuit has been filed against Beyond Meat, Inc. for allegedly misrepresenting its financial condition, particularly regarding impairment charges related to long-lived assets, which led to significant stock price declines and investor harm [1]. Company Overview - Beyond Meat, headquartered in El Segundo, California, specializes in developing and marketing plant-based meat products under the "Beyond" brand name [1]. Legal Proceedings - The lawsuit pertains to investors who acquired Beyond Meat securities between February 27, 2025, and November 11, 2025, with a deadline for lead plaintiff applications set for March 24, 2026 [1]. - The complaint claims that Beyond Meat failed to disclose that the book value of certain long-lived assets exceeded their fair value, making a material non-cash impairment charge likely [1]. - Following disclosures starting October 24, 2025, Beyond Meat reported $77.4 million in impairment charges, which negatively impacted the company's stock price and harmed investors [1].

PHILADELPHIA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against Enphase Energy, Inc. (NASDAQ: ENPH) (“Enphase” or the “Company”) on behalf of investors who purchased or otherwise acquired Enphase securities during the period from April 22, 2025 through October 28, 2025 (the “Class Period”). Investor Deadline: Investors who purchased Enphase securities during the Class Period may, no later than April 20, 2026, seek ...

Core Viewpoint - A class action lawsuit has been filed against uniQure N.V. for allegedly misrepresenting information regarding its drug AMT-130 during a specific class period, leading to significant stock price decline [1]. Company Overview - uniQure N.V. is a biotechnology company based in Amsterdam, focusing on gene therapies for severe diseases, including Huntington's disease [1]. Legal Allegations - The lawsuit claims that uniQure misrepresented the FDA approval status of its Pivotal Study for AMT-130 and downplayed the potential delay in its Biologics License Application (BLA) timeline [1]. - The complaint highlights that the FDA did not agree that the Phase I/II data could serve as primary evidence for a BLA submission, causing uncertainty regarding the submission timeline [1]. Stock Performance Impact - Following the disclosure on November 3, 2025, uniQure's stock plummeted over 49%, dropping from $67.69 per share on October 31, 2025, to $34.29 per share the next trading day [1].

Philadelphia, Pennsylvania--(Newsfile Corp. - February 23, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Masonite International Corporation (NYSE: DOOR) ("Masonite" or the "Company") on behalf of investors who sold Masonite common stock during the period from June 5, 2023 through February 8, 2024 (the "Class Period").Investor Deadline: Investors who sold Masonite securities during the Class Period may, no later than April 7, 2026, seek ...

PHILADELPHIA, Feb. 23, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against Fermi Inc. (NASDAQ: FRMI) (“Fermi” or the “Company”) on behalf of investors who purchased or otherwise acquired Fermi securities during the period of October 1, 2025 through December 11, 2025 (the “Class Period”), including in the Company’s initial public offering on October 1, 2025. Investor Deadline: Investors who purchased Fermi securities during th ...

Core Viewpoint - A class action lawsuit has been filed against NuScale Power Corporation for allegedly misleading investors regarding its commercialization partner and financial disclosures during a specific period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired NuScale securities from May 13, 2025, to November 6, 2025 [1][2]. - Investors have until April 20, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Allegations - The complaint alleges that NuScale misrepresented its exclusive commercialization partner, ENTRA1 Energy LLC, claiming it lacked meaningful experience in nuclear power projects [3]. - It is also alleged that the qualifications attributed to ENTRA1 were actually related to the Habboush Group, which has no significant nuclear energy experience [3]. - The commercialization strategy of NuScale was said to be exposed to undisclosed risks, including potential failures and regulatory challenges [3]. Group 3: Financial Impact - On November 6, 2025, NuScale reported a more than 3,000% increase in general and administrative expenses, totaling $519 million for the third fiscal quarter, primarily due to a $495 million payment to ENTRA1 [4]. - The company's net loss for the quarter was reported at $532 million [4]. - Following this disclosure, NuScale's Class A shares fell over 12%, from $32.46 on November 6, 2025, to $28.43 on November 10, 2025 [5].